250 related articles for article (PubMed ID: 28393599)
1. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
Jakó J; Szerafin L
Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiologic features of myeloma in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
Jakó J; Szerafin L
Orv Hetil; 2016 Aug; 157(34):1357-60. PubMed ID: 27546802
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
[TBL] [Abstract][Full Text] [Related]
4. [Anteposition in malignant hematologic diseases of siblings in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 34-year period].
Jakó J; Szerafin L
Orv Hetil; 2017 Aug; 158(33):1283-1287. PubMed ID: 28806110
[TBL] [Abstract][Full Text] [Related]
5. [Extranodal lymphomas in adults in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of 30 years' epidemiologic data].
Jakó J; Szerafin L
Orv Hetil; 2015 Jan; 156(3):98-104. PubMed ID: 25577681
[TBL] [Abstract][Full Text] [Related]
6. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 36-year period].
Jakó J; Takács P; Szerafin L
Orv Hetil; 2020 Aug; 161(34):1400-1413. PubMed ID: 32804670
[TBL] [Abstract][Full Text] [Related]
7. [Incidence of myocardial infarction in Hungary. Population study in five districts of Budapest and Szabolcs-Szatmár-Bereg county].
Jánosi A; Ofner P; Branyickiné Géczy G; Polgár P
Orv Hetil; 2013 Jul; 154(28):1106-10. PubMed ID: 23835356
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial Infarction Registry--2010. Experience and first results in Hungary].
Jánosi A; Ofner P; Merkely B; Polgár P; Andréka P; Zámolyi K; Kiss RG; Tomcsányi J; László Z; Vértes A; Varjú I; Juhász F; Simon J; Bajkó S
Orv Hetil; 2011 Aug; 152(32):1278-83. PubMed ID: 21803725
[TBL] [Abstract][Full Text] [Related]
9. [Development of the registry for Philadelphia-negative chronic myeloproliferative neoplasia in Hungary].
Dombi P; Illés Á; Demeter J; Homor L; Simon Z; Udvardy M; Egyed M
Orv Hetil; 2016 Jan; 157(3):98-103. PubMed ID: 26750731
[TBL] [Abstract][Full Text] [Related]
10. [Current data on familial occurrence of malignant hematologic diseases in the County of Szabolcs-Szatmár-Bereg in Hungary].
Jakó J; Szerafin L; Nagy P; Babicz T
Orv Hetil; 1998 Sep; 139(37):2187-9. PubMed ID: 9769687
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence of associated tumours in chronic lymphocytic leukemia].
Szerafin L; Jakó J; Varju L
Orv Hetil; 2016 Oct; 157(44):1752-1756. PubMed ID: 27796128
[TBL] [Abstract][Full Text] [Related]
12. [Anemia in pregnancy: characteristics in Szabolcs-Szatmár-Bereg County, Hungary].
Szerafin L; Jakó J
Orv Hetil; 2010 Aug; 151(33):1347-52. PubMed ID: 20693146
[TBL] [Abstract][Full Text] [Related]
13. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
[TBL] [Abstract][Full Text] [Related]
14. Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.
Johansson P; Kutti J; Andréasson B; Safai-Kutti S; Vilén L; Wedel H; Ridell B
J Intern Med; 2004 Aug; 256(2):161-5. PubMed ID: 15257729
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the data from the Szabolcs-Szatmár County 1983-1987 leukemia/lymphoma registry].
Jakó J; Nagy P
Orv Hetil; 1990 Feb; 131(8):411-4. PubMed ID: 2314880
[TBL] [Abstract][Full Text] [Related]
16. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis.
Kutti J; Ridell B
Pathol Biol (Paris); 2001 Mar; 49(2):164-6. PubMed ID: 11317963
[TBL] [Abstract][Full Text] [Related]
18. [An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the essential thrombocythaemic patients].
Dombi P; Illés Á; Demeter J; Homor L; Simon Z; Udvardy M; Karádi É; Kellner Á; Egyed M
Orv Hetil; 2017 Jan; 158(3):111-116. PubMed ID: 28110571
[TBL] [Abstract][Full Text] [Related]
19. [Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the Polycythemia vera patients].
Dombi P; Illés Á; Demeter J; Homor L; Simon Z; Kellner Á; Karádi É; Valasinyószki E; Udvardy M; Egyed M
Orv Hetil; 2017 Jun; 158(23):901-909. PubMed ID: 28580853
[TBL] [Abstract][Full Text] [Related]
20. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]